Two Sigma Advisers’s VivoSim Labs VIVS Stock Holding History

Two Sigma Advisers’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-889	Closed	-$39K	–	2944
2021 Q4	$39K	Buy	+889	New	+$57.2K	﹤0.01%	2497

Other funds holding VIVS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's VIVS Position: Q1 2022 in Review

Two Sigma Advisers sold out of VivoSim Labs (VIVS) in Q1 2022, closing a stake of 889 shares — an estimated $39K sold.

Two Sigma Advisers first reported a position in VIVS in Q4 2021 and held it in 1 quarter. The position peaked at $39K in Q4 2021. 37 funds tracked by Wall St. Rank hold VIVS as of Q1 2022.

Two Sigma Advisers reported no remaining VivoSim Labs position as of Q1 2022 after selling out during the quarter.
Two Sigma Advisers sold 889 VivoSim Labs shares in Q1 2022, an estimated $39K.
Two Sigma Advisers first reported a position in VivoSim Labs in Q4 2021 and held it in 1 quarter.
Two Sigma Advisers's VivoSim Labs position peaked at $39K in Q4 2021.
37 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.